BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9602031)

  • 1. Electrostatic interaction between NADH-cytochrome b5 reductase and cytochrome b5 studied by site-directed mutagenesis.
    Shirabe K; Nagai T; Yubisui T; Takeshita M
    Biochim Biophys Acta; 1998 Apr; 1384(1):16-22. PubMed ID: 9602031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase.
    Kawano M; Shirabe K; Nagai T; Takeshita M
    Biochem Biophys Res Commun; 1998 Apr; 245(3):666-9. PubMed ID: 9588172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lysyl residues of NADH-cytochrome b5 reductase implicated in charge-pairing with active-site carboxyl residues of cytochrome b5 by site-directed mutagenesis of an expression vector for the flavoprotein.
    Strittmatter P; Kittler JM; Coghill JE; Ozols J
    J Biol Chem; 1992 Feb; 267(4):2519-23. PubMed ID: 1370824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic properties deduced from refined structures of NADH-cytochrome b5 reductase and the other flavin-dependent reductases: pyridine nucleotide-binding and interaction with an electron-transfer partner.
    Nishida H; Miki K
    Proteins; 1996 Sep; 26(1):32-41. PubMed ID: 8880927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cysteine residues in human NADH-cytochrome b5 reductase studied by site-directed mutagenesis. Cys-273 and Cys-283 are located close to the NADH-binding site but are not catalytically essential.
    Shirabe K; Yubisui T; Nishino T; Takeshita M
    J Biol Chem; 1991 Apr; 266(12):7531-6. PubMed ID: 2019583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Lys-110 of human NADH-cytochrome b5 reductase in NADH binding as probed by site-directed mutagenesis.
    Fujimoto Y; Shirabe K; Nagai T; Yubisui T; Takeshita M
    FEBS Lett; 1993 May; 322(1):30-2. PubMed ID: 8482363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.
    Peng HM; Liu J; Forsberg SE; Tran HT; Anderson SM; Auchus RJ
    J Biol Chem; 2014 Dec; 289(49):33838-49. PubMed ID: 25315771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the covalent cross-links of the active sites of amidinated cytochrome b5 and NADH:cytochrome b5 reductase.
    Strittmatter P; Hackett CS; Korza G; Ozols J
    J Biol Chem; 1990 Dec; 265(35):21709-13. PubMed ID: 2123873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
    Davis CA; Dhawan IK; Johnson MK; Barber MJ
    Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous purification and characterization of cytochrome b5 reductase and cytochrome b5 from sheep liver.
    Arinç E; Cakir D
    Int J Biochem Cell Biol; 1999 Feb; 31(2):345-62. PubMed ID: 10216966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction.
    Lamb DC; Kelly DE; Manning NJ; Kaderbhai MA; Kelly SL
    FEBS Lett; 1999 Dec; 462(3):283-8. PubMed ID: 10622712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of cytochrome b5 for studies of its interaction with cytochrome P450.
    Chudaev MV; Gilep AA; Usanov SA
    Biochemistry (Mosc); 2001 Jun; 66(6):667-81. PubMed ID: 11421817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flavin-binding motif amino acid mutations in the NADH-cytochrome b5 reductase catalytic domain on protein stability and catalysis.
    Kimura S; Nishida H; Iyanagi T
    J Biochem; 2001 Oct; 130(4):481-90. PubMed ID: 11574067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADH-cytochrome b5 reductase and cytochrome b5. The problem of posttranslational targeting to the endoplasmic reticulum.
    Borgese N; D'Arrigo A; De Silvestris M; Pietrini G
    Subcell Biochem; 1993; 21():313-41. PubMed ID: 8256272
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of Electrostatics to the Kinetics of Electron Transfer from NADH-Cytochrome b5 Reductase to Fe(III)-Cytochrome b5.
    Kollipara S; Tatireddy S; Pathirathne T; Rathnayake LK; Northrup SH
    J Phys Chem B; 2016 Aug; 120(33):8193-207. PubMed ID: 27059440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural role of serine 127 in the NADH-binding site of human NADH-cytochrome b5 reductase.
    Yubisui T; Shirabe K; Takeshita M; Kobayashi Y; Fukumaki Y; Sakaki Y; Takano T
    J Biol Chem; 1991 Jan; 266(1):66-70. PubMed ID: 1898726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient kinetics of intracomplex electron transfer in the human cytochrome b5 reductase-cytochrome b5 system: NAD+ modulates protein-protein binding and electron transfer.
    Meyer TE; Shirabe K; Yubisui T; Takeshita M; Bes MT; Cusanovich MA; Tollin G
    Arch Biochem Biophys; 1995 Apr; 318(2):457-64. PubMed ID: 7733677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent.
    Bewley MC; Marohnic CC; Barber MJ
    Biochemistry; 2001 Nov; 40(45):13574-82. PubMed ID: 11695905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
    Marohnic CC; Bewley MC; Barber MJ
    Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADH-cytochrome b5 reductase and cytochrome b5 isoforms as models for the study of post-translational targeting to the endoplasmic reticulum.
    Borgese N; D'Arrigo A; De Silvestris M; Pietrini G
    FEBS Lett; 1993 Jun; 325(1-2):70-5. PubMed ID: 8513896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.